Align Technology, Inc. (NASDAQ:ALGN) Shares Bought by Natixis Advisors LLC

Natixis Advisors LLC boosted its position in shares of Align Technology, Inc. (NASDAQ:ALGN - Free Report) by 71.5% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 31,996 shares of the medical equipment provider's stock after purchasing an additional 13,342 shares during the quarter. Natixis Advisors LLC's holdings in Align Technology were worth $6,671,000 at the end of the most recent reporting period.

Several other large investors also recently bought and sold shares of the company. Wellington Management Group LLP boosted its position in shares of Align Technology by 49.0% in the 3rd quarter. Wellington Management Group LLP now owns 2,634,600 shares of the medical equipment provider's stock worth $670,031,000 after buying an additional 866,663 shares in the last quarter. Geode Capital Management LLC lifted its holdings in shares of Align Technology by 1.2% in the third quarter. Geode Capital Management LLC now owns 1,750,805 shares of the medical equipment provider's stock valued at $443,810,000 after purchasing an additional 21,605 shares in the last quarter. FMR LLC grew its position in shares of Align Technology by 43.0% in the third quarter. FMR LLC now owns 1,221,831 shares of the medical equipment provider's stock valued at $310,736,000 after purchasing an additional 367,508 shares during the last quarter. Ninety One UK Ltd increased its stake in shares of Align Technology by 3.7% during the 4th quarter. Ninety One UK Ltd now owns 1,220,601 shares of the medical equipment provider's stock worth $254,508,000 after purchasing an additional 43,524 shares in the last quarter. Finally, Meridiem Investment Management Ltd. raised its position in shares of Align Technology by 63.7% during the 4th quarter. Meridiem Investment Management Ltd. now owns 764,732 shares of the medical equipment provider's stock worth $159,470,000 after purchasing an additional 297,472 shares during the last quarter. Institutional investors and hedge funds own 88.43% of the company's stock.

Remove Ads

Analysts Set New Price Targets

Several equities analysts have weighed in on the company. Leerink Partnrs raised Align Technology from a "hold" rating to a "strong-buy" rating in a research report on Monday, January 6th. Jefferies Financial Group dropped their price objective on Align Technology from $285.00 to $260.00 and set a "buy" rating for the company in a research report on Thursday, January 23rd. Bank of America boosted their target price on shares of Align Technology from $200.00 to $206.00 and gave the company an "underperform" rating in a research note on Friday, December 13th. Leerink Partners raised shares of Align Technology from a "market perform" rating to an "outperform" rating and raised their price target for the stock from $235.00 to $280.00 in a research note on Monday, January 6th. Finally, Morgan Stanley cut their price objective on shares of Align Technology from $280.00 to $272.00 and set an "overweight" rating for the company in a research report on Thursday, February 6th. One investment analyst has rated the stock with a sell rating, two have issued a hold rating, ten have given a buy rating and one has assigned a strong buy rating to the company's stock. Based on data from MarketBeat, the stock currently has an average rating of "Moderate Buy" and an average price target of $266.73.

Align Technology Stock Performance

Shares of ALGN traded up $1.76 during trading hours on Monday, hitting $170.37. The stock had a trading volume of 726,808 shares, compared to its average volume of 803,505. Align Technology, Inc. has a 12-month low of $158.13 and a 12-month high of $331.64. The firm has a market cap of $12.54 billion, a P/E ratio of 30.37, a P/E/G ratio of 2.24 and a beta of 1.69. The company's fifty day simple moving average is $197.91 and its 200 day simple moving average is $216.13.

Align Technology (NASDAQ:ALGN - Get Free Report) last announced its quarterly earnings results on Wednesday, February 5th. The medical equipment provider reported $1.96 EPS for the quarter, missing the consensus estimate of $2.43 by ($0.47). Align Technology had a return on equity of 13.84% and a net margin of 10.54%. As a group, sell-side analysts predict that Align Technology, Inc. will post 7.98 earnings per share for the current fiscal year.

Align Technology Company Profile

Align Technology, Inc designs, manufactures, and markets Invisalign clear aligners, and iTero intraoral scanners and services for orthodontists and general practitioner dentists in the United States, Switzerland, and internationally. The company's Clear Aligner segment offers comprehensive products, including Invisalign comprehensive package that addresses the orthodontic needs of younger patients, such as mandibular advancement, compliance indicators, and compensation for tooth eruption; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients generally between the ages of six and ten years, which is a mixture of primary/baby and permanent teeth.